Skip to content

Our Portfolio

Raze Therapeutics

Raze Therapeutics, is developing the next generation of oncology therapeutics that target metabolic pathways essential to cancer growth and survival. Using their proprietary platform, they are developing a pipeline of selective therapeutics for specific solid and hematologic cancers.